Clinical Trial Update: Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Everolimus- and Biolimus-eluting stents with Everolimus-eluting bioresorbable vascular scaffolds in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biolimus-eluting stents (biolimus-eluting stent)
• Everolimus-eluting bioresorbable vascular scaffold stents (everolimus-eluting bioresorbable vascular scaffold)
• Everolimus-eluting stents (everolimus-eluting stent)

Snippet

Sponsor: University of Freiburg | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED